Anthrax Diagnosis
Rapid dermatology referral system during anthrax outbreak described
Published in Medical Letter on the CDC and FDA, August 7th, 2005
According to a study from the United States, "The bioterrorism-related anthrax outbreak generated unanticipated demand for dermatologic services. In this study we sought to perform rapid, efficient, cost-effective evaluation of patients suspected of having cutaneous anthrax. During the outbreak, we developed an anthrax evaluation system featuring clinical field examination by nondermatologist physicians, followed by rapid referral of selected high-risk patients to a centralized dermatology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Emerging Pathogen
Primate T-lymphotropic viruses reported in African bushmeat hunters - Hepatitis C Virus
Outbreak of hepatitis C at hematology/oncology clinic reported - Suicide Risk Factors
Adolescents at BMI extremes have increased risk of suicide attempts - West Nile Virus Vaccine
Chimeric dengue/West Nile viruses protect against lethal challenge - Amyloid A Amyloidosis
FDA agrees to review NDA for Fibrillex, recruitment for Alzhemed trial complete - Angina
Company announces submission of IDE protocol to FDA for PMC clinical trial - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
